C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
260/237.6
C07D 489/08 (2006.01) A61K 31/47 (2006.01) A61K 31/485 (2006.01) C07D 221/28 (2006.01) C07D 489/02 (2006.01) C07D 519/00 (2006.01)
Patent
CA 1258674
ABSTRACT OF THE DISCLOSURE Dihydromorphinone compound of the general formula HDM=N-R wherein HDM is Image where * indicates binding carbon R1 is an optionally substituted alkyl, alkylene, cycloalkyl, or cycloalkylene R2 is OH or H R3 is OH or OCH3 and R is N=R4, N-R4, Image NN=R4 R4 is an optionally substituted alkyl, alkylene, cycloalkyl, cycloalkylene, aryl, heterocycloalkyl, hetero- cycloalkylene, or alkenyl, and n is 1-10. This compound is useful for irreversibly blocking opiate receptor binding.
413566
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Sloan-Kettering Institute For Cancer Research
LandOfFree
Opiate agonists and antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Opiate agonists and antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Opiate agonists and antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1271915